These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6578007)

  • 1. Additive pulmonary toxicity with melphalan and busulfan therapy.
    Schallier D; Impens N; Warson F; Van Belle S; De Wasch G
    Chest; 1983 Oct; 84(4):492-3. PubMed ID: 6578007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary fibrosis after busulfan therapy].
    Jandl H; Franke A; Albrecht G
    Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Busulfan lung.
    Pearl M
    Am J Dis Child; 1977 Jun; 131(6):650-2. PubMed ID: 266839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Busulfan lung. Pulmonary fibrosis caused by Myleran].
    Koch H; Lesch R
    Med Welt; 1976 Feb; 27(7):308-11. PubMed ID: 1062649
    [No Abstract]   [Full Text] [Related]  

  • 5. Busulfan lung. Report of two cases and review of the literature.
    Podoll LN; Winkler SS
    Am J Roentgenol Radium Ther Nucl Med; 1974 Jan; 120(1):151-6. PubMed ID: 4520939
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fatal pulmonary fibrosis, with cellular lesions of the lung and pancreas, attributed to busulfan].
    Batzenschlager A; Oberling F; Guerbaoui M; Vetter JM
    Arch Anat Pathol (Paris); 1972 Sep; 20(3):291-4. PubMed ID: 4507846
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary alveolar fibrosis caused by Myleran (busulfan)].
    Etcheberry R; Becker P; Delmastro J; Donoso S
    Rev Med Chil; 1973 Jan; 101(1):42-6. PubMed ID: 4518637
    [No Abstract]   [Full Text] [Related]  

  • 8. [Undesired side-effects of busulfan].
    Japp H
    Dtsch Med Wochenschr; 1974 Dec; 99(51):2614-5. PubMed ID: 4530768
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myleran lung in chronic myelosis].
    Pietschmann H; Kolarz G
    Wien Z Inn Med; 1973; 54(4):150-5. PubMed ID: 4519579
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis of busulfan lung by transcatheter biopsy.
    Brynes RK; Mostafavipour SH; Fennessy JJ; Variakojis D
    Chest; 1973 Dec; 64(6):771-3. PubMed ID: 4519106
    [No Abstract]   [Full Text] [Related]  

  • 11. [Busulfan-induced pneumopathy].
    Massin F; Fur A; Reybet-Degat O; Camus P; Jeannin L
    Rev Mal Respir; 1987; 4(1):3-10. PubMed ID: 3473580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary toxicity recurring after a six week course of busulfan therapy and after subsequent therapy with uracil mustard.
    Hankins DG; Sanders S; MacDonald FM; Drage CW
    Chest; 1978 Mar; 73(3):415-6. PubMed ID: 272980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150).
    Jung SH; Lee JJ; Kim JS; Min CK; Kim K; Choi Y; Eom HS; Joo YD; Kim SH; Kwak JY; Kang HJ; Lee JH; Lee HS; Mun YC; Moon JH; Sohn SK; Park SK; Park Y; Shin HJ; Yoon SS;
    Biol Blood Marrow Transplant; 2018 May; 24(5):923-929. PubMed ID: 29339269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial pulmonary fibrosis, atypical epithelial changes and bronchiolar cell carcinoma following busulfan therapy.
    Min KW; Györkey F
    Cancer; 1968 Nov; 22(5):1027-32. PubMed ID: 4301103
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of pulmonary fibrosis due to misulban].
    Douay B; Leduc M; Beaugeard D
    Lille Med; 1979 Apr; 24(4):292-4. PubMed ID: 289887
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical heterogeneity of Myleran-induced pneumopathy. Apropos of 2 further cases and review of the literature].
    Gyger M; LeGresley LP; Boulianne P; Lacombe M; Lavallée R; Bonny Y; Boileau J; D'Angelo G
    Union Med Can; 1977 Nov; 106(11):1522-8. PubMed ID: 270864
    [No Abstract]   [Full Text] [Related]  

  • 17. Busulfan-induced pulmonary disease. Report of a case and review of the literature.
    Burns WA; McFarland W; Matthews MJ
    Am Rev Respir Dis; 1970 Mar; 101(3):408-13. PubMed ID: 5263678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term results of busulfan treatment].
    Comhaire F; Van der Straeten M; Van Hove W; Van Ganse W; Roels H
    Acta Tuberc Pneumol Belg; 1970; 61(5):471-80. PubMed ID: 5281036
    [No Abstract]   [Full Text] [Related]  

  • 19. Iron Overload Exacerbates Busulfan-Melphalan Toxicity Through a Pharmacodynamic Interaction in Mice.
    Bouligand J; Richard C; Valteau-Couanet D; Orear C; Mercier L; Kessari R; Simonnard N; Munier F; Daudigeos-Dubus E; Tou B; Opolon P; Deroussent A; Paci A; Vassal G
    Pharm Res; 2016 Aug; 33(8):1913-22. PubMed ID: 27091031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia.
    Kirschner RH; Esterly JR
    Cancer; 1971 May; 27(5):1074-80. PubMed ID: 5281244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.